Intra-arterial Autologous Bone Marrow Cell Transplantation in a Patient with Upper-extremity Critical Limb Ischemia

Journal Article · Mon Apr 15 00:00:00 EDT 2013 · Cardiovascular and Interventional Radiology

DOI:https://doi.org/10.1007/S00270-012-0415-Z· OSTI ID:22156382

Madaric, Juraj ^[1]; Klepanec, Andrej ^[2]; Mistrik, Martin ^[3]; Altaner, Cestmir ^[4]; Vulev, Ivan ^[2]

---

1. National Institute of Cardiovascular Diseases (NUSCH) and Slovak Medical University, Department of Cardiology and Angiology (Slovakia)
2. National Institute of Cardiovascular Diseases, Department of Diagnostic and Interventional Radiology (Slovakia)
3. Clinic of Hematology and Transfusiology, Faculty Hospital (Slovakia)
4. Slovak Academy of Science, Institute of Experimental Oncology (Slovakia)

Induction of therapeutic angiogenesis by autologous bone marrow mononuclear cell transplantation has been identified as a potential new option in patients with advanced lower-limb ischemia. There is little evidence of the benefit of intra-arterial cell application in upper-limb critical ischemia. We describe a patient with upper-extremity critical limb ischemia with digital gangrene resulting from hypothenar hammer syndrome successfully treated by intra-arterial autologous bone marrow mononuclear cell transplantation.

• OSTI ID: 22156382
• Journal Information: Cardiovascular and Interventional Radiology, Vol. 36, Issue 2; Other Information: Copyright (c) 2013 Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE); Article Copyright (c) 2012 Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE); Country of input: International Atomic Energy Agency (IAEA); ISSN 0174-1551
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
ANGIOGENESIS
BONE MARROW
BONE MARROW CELLS
GANGRENE
ISCHEMIA
LIMBS
PATIENTS